Abstract
Background: Herbomineral formulations are being successfully used in Ayurvedic therapeutics since centuries. Though the preclinical safety of these formulations is established, there have been reports questioning the safety of their metallic contents, especially the presence of heavy metals. As such, it becomes imperative for the contemporary practitioners of Ayurveda to document and publish their observations on the safety of classical herbomineral formulations; as such studies will enable the scientific community to believe traditional systems too as evidence based on account of safety and efficacy.
Aim: The current work was an observational study in effort to document the safety of Chandraprabha Vati with objective
to review and report dose related adverse effects and its safety.
Method: The study data was collected from the hospital software records to survey the prescription patterns in the regular OPD and also to report any untoward affects of Chandraprabha Vati. The dose related adverse effects / safety of Chandraprabha Vati were reviewed and the observations were reported.
Results & Conclusion: There were no serious adverse reactions or toxicity symptoms with Chandraprabha Vati administered orally at doses of 500-1000 mg/ day given over 1 - 4 months.
Conclusion: Chandraprabha Vati, an Ayurvedic metallo-herbo- mineral formulation is safe when administered in prescribed doses.

Key words: Chandraprabha Vati, Heavy metal, Herbomineral, Safety

Similar Articles

Safety and efficacy of dietary supplement (gintonin-enriched fraction from ginseng) in subjective memory impairment: A randomized placebo-controlled trial.
Lee WJ, Shin YW, Chang H, Shin HR, Kim WW, Jung SW, Kim M, Nah SY
Integrative medicine research. 2022; 11(1): 100773

The effectiveness and safety of complementary health approaches to managing postpartum pain: A systematic review and meta-analysis.
Smith CA, Hill E, Denejkina A, Thornton C, Dahlen HG
Integrative medicine research. 2022; 11(1): 100758

Biodegradation behaviour of Fe-based alloys in Hanks' Balanced Salt Solutions: Part II. The evolution of local pH and dissolved oxygen concentration at metal interface.
Wang C, Tonna C, Mei D, Buhagiar J, Zheludkevich ML, Lamaka SV
Bioactive materials. 2022; 7(): 412-425

Four Novel d Metal-Organic Frameworks Incorporating Amino-Functionalized Carboxylate Ligands: Synthesis, Structures, and Fluorescence Properties.
Xie W, Wu J, Hang X, Zhang H, Shen K, Wang Z
Frontiers in chemistry. 2021; 9(): 708314

Safety of 3-FL (3-Fucosyllactose) as a novel food pursuant to Regulation (EU) 2015/2283.
, Turck D, Castenmiller J, De Henauw S, Hirsch-Ernst KI, Kearney J, Maciuk A, Mangelsdorf I, McArdle HJ, Naska A, Pelaez C, Pentieva K, Siani A, Thies F, Tsabouri S, Vinceti M, Cubadda F, Frenzel T, Heinonen M, Marchelli R, Neuhäuser-Berthold M, Poulsen M, Maradona MP, Schlatter JR, van Loveren H, Colombo P, Knutsen HK
EFSA journal. European Food Safety Authority. 2021; 19(6): e06662